Titan Biotech Ltd Share Price
(524717)
₹494.9
as on 04:01PM, 23 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.28 % |
3 Month Return | -33.87 % |
1 Year Return | + 0.25 % |
Market Stats | |
Previous Close | ₹497.60 |
Open | ₹509.10 |
Volume | 3,558.00 |
Upper Circuit | ₹597.10 |
Lower Circuit | ₹398.10 |
Market Cap | ₹411.20Cr |
P/E Ratio
18.29
PEG Ratio
-6.29
Market Cap
₹411.20 Cr
P/B Ratio
3.4
EPS
28.64
Dividend Yield
0.38
Sector
Pharmaceuticals
ROE
20.18
Titan Biotech Reports Decline in Sales and Profit - 17 Feb, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 56.6%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 52.0%
Revenue Fall
Revenue is down for the last 3 quarters, 43.74 Cr → 39.87 Cr (in ₹), with an average decrease of 4.5% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 44.12% to 44.11% in Mar 2025 quarter
Price Dip
In the last 3 months, Titan Biotech stock has moved down by -33.9%
Profit Down
Netprofit is down for the last 2 quarters, 6.7 Cr → 4.39 Cr (in ₹), with an average decrease of 34.5% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 55.88% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.11% | 0.00 | |
Others | 0.01% | 0.00 |
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (18.29x)
April 22, 2025
Industry (53.69x)
April 22, 2025
Highest (32.11x)
October 21, 2024
Titan Biotech Ltd’s net profit fell -38.77% since last year same period to ₹4.39Cr in the Q3 2024-2025. On a quarterly growth basis, Titan Biotech Ltd has generated -34.48% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2 - translating a dividend yield of 0.77%.
Read More about DividendsBearish
Neutral
Bullish
Titan Biotech Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹411.20 Cr | 183.1% | 0.54 | ₹23 Cr | ₹164 Cr | |
NA | ₹1,937.63 Cr | 13.81% | 0.79 | NA | NA | |
NA | ₹2,170.92 Cr | 31.02% | 0.51 | ₹58 Cr | ₹630 Cr | |
NA | ₹43.65 Cr | 79.36% | 0.81 | NA | NA | |
NA | ₹368.62 Cr | 42.08% | 0.51 | NA | NA |
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Titan Biotech Ltd share price today stands at ₹494.9, Open: ₹509.1, Previous Close: ₹497.6, High: ₹510.65, Low: ₹488, 52 Week High: ₹1017.85, 52 Week Low: ₹406.7.
Today's traded volume of Titan Biotech Ltd(524717) is 3,558.00.
Today's market capitalisation of Titan Biotech Ltd(524717) is ₹411.2Cr.
Titan Biotech Ltd (524717) share price is ₹494.9. It is down -51.38% from its 52 Week High price of ₹1017.85
Titan Biotech Ltd (524717) share price is ₹494.9. It is up 21.69% from its 52 Week Low price of ₹406.7